Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure (Q77212706)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730105%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

title

Beta-receptor blockade decreases carnitine palmitoyl transferase I activity in dogs with heart failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730105%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

author name string

A R Panchal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730105%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

W C Stanley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730105%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

J Kerner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730105%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

H N Sabbah

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730105%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

publication date

1 June 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730105%20AND%20SRC:MED&resulttype=core&format=json

Journal of Cardiac Failure

3 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730105%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730105%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

page(s)

121-126

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730105%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730105%20AND%20SRC:MED&resulttype=core&format=json

Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.

3 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Carvedilol inhibits clinical progression in patients with mild symptoms of heart failure. US Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure. The PRECISE Trial. Prospective Randomized Evaluation of Carvedilol on Symptoms and Exercise.

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

The link between acute haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure. A study on diastolic function, heart rate and myocardial metabolism following intravenous metoprolol

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Hemodynamic and energetic comparison of bucindolol and metoprolol for the treatment of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Effects of long-term monotherapy with enalapril, metoprolol, and digoxin on the progression of left ventricular dysfunction and dilation in dogs with reduced ejection fraction

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Modification of sarcoplasmic reticulum gene expression in pressure overload cardiac hypertrophy by etomoxir

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Etomoxir improves left ventricular performance of pressure-overloaded rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

An acyl-coenzyme A dehydrogenase assay utilizing the ferricenium ion

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Transcriptional regulation by glucocorticoids of mitochondrial oxidative enzyme genes in the developing rat kidney

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Effect of Free Fatty Acids on Myocardial Function and Oxygen Consumption in Intact Dogs

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Effect of antilipolytic therapy on ST segment elevation during myocardial ischaemia in man

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Fatty acid oxidation enzyme gene expression is downregulated in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

Metabolic and cardiovascular benefits deriving from beta-adrenergic blockade in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS1071-9164%2898%2990252-4

7 January 2021

10.1016/S1071-9164(98)90252-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9730105%20AND%20SRC:MED&resulttype=core&format=json

3 December 2019

1 reference